The US Food and Drug Administration (FDA) has cleared another blood test that could help doctors identify whether a patient’s memory problems are likely caused by Alzheimer’s disease.
IDH1 inhibitors show strong efficacy and tolerability in IDH1-mutated AML and MDS, with some patients achieving long-term ...
A new human liver organoid platform could help predict which drugs trigger dangerous immune reactions in susceptible patients ...
Discover how hidden mold impacts your home’s health — and how designers are using smart materials and airflow to stop it ...
Oncologists and pharmacy experts are reacting to last week's Food and Drug Administration warning that requires genetic testing on patients receiving the common chemotherapy drug capecitabine (Xeloda® ...
MoldCo is here to change that with clinical rigor based on 30+ years of research, affordability, and accessibility—redefining a space long characterized by confusion, cost, and neglect.
Whitehawk Therapeutics shares are rising Thursday after the company announced a multi-year collaboration with Tempus AI to ...
In the histology-centric world of cancer medicine, further work is needed to increase genomic testing rates and educate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback